federal_register: 2011-33550
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-33550 | Draft Guidance for Industry on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices." This draft guidance responds to stakeholder requests for specific guidance on FDA's current views on how manufacturers and distributors (firms) of prescription human and animal drug products and medical devices can respond to unsolicited requests for information about unapproved or uncleared indications or conditions of use (off- label information) related to their FDA-approved or cleared products. This draft guidance updates and clarifies FDA's policies on unsolicited requests for off-label information, including those that firms may encounter through emerging electronic media. | 2011-12-30 | 2011 | 12 | https://www.federalregister.gov/documents/2011/12/30/2011-33550/draft-guidance-for-industry-on-responding-to-unsolicited-requests-for-off-label-information-about | https://www.govinfo.gov/content/pkg/FR-2011-12-30/pdf/2011-33550.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices." This draft guidance responds to... |